HealthCare Global Enterprises (NSE:HCG) Cyclically Adjusted Revenue per Share: ₹144.84 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
82 GF Score
Price ₹670.95
GF Value ₹581.71
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises Cyclically Adjusted Revenue per Share?

HealthCare Global Enterprises NSE:HCG +1.47% 82 Cyclically Adjusted Revenue per Share is ₹144.84 as of Mar. 2026. GuruFocus rates NSE:HCG with a GF Score™ of 82/100 and a GF Value™ of ₹581.71 (Modestly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

HealthCare Global Enterprises's adjusted revenue per share for the three months ended in Mar. 2026 was ₹44.951. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹144.84 for the trailing ten years ended in Mar. 2026.

During the past 12 months, HealthCare Global Enterprises's average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-23), HealthCare Global Enterprises's current stock price is ₹670.95. HealthCare Global Enterprises's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹144.84. HealthCare Global Enterprises's Cyclically Adjusted PS Ratio of today is 4.63.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of HealthCare Global Enterprises was 5.39. The lowest was 3.53. And the median was 4.19.


HealthCare Global Enterprises  (NSE:HCG) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

HealthCare Global Enterprises's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=670.95/144.84
=4.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of HealthCare Global Enterprises was 5.39. The lowest was 3.53. And the median was 4.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


HealthCare Global Enterprises Cyclically Adjusted Revenue per Share Related Terms


HealthCare Global Enterprises Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for HealthCare Global Enterprises's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises Cyclically Adjusted Revenue per Share Chart

HealthCare Global Enterprises Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 132.80 144.84

HealthCare Global Enterprises Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.80 136.52 140.12 142.40 144.84

NSE:HCG vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, HealthCare Global Enterprises's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthCare Global Enterprises Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where HealthCare Global Enterprises's Cyclically Adjusted PS Ratio falls into.


NSE:HCG
82GF Score
HealthCare Global Enterprises Ltd NSE:HCG
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthCare Global Enterprises Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HealthCare Global Enterprises's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=44.951/164.2724*164.2724
=44.951

Current CPI (Mar. 2026) = 164.2724.

HealthCare Global Enterprises Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 19.610 105.961 30.402
201609 20.301 105.961 31.473
201612 20.288 105.196 31.681
201703 24.113 105.196 37.654
201706 22.084 107.109 33.870
201709 24.519 109.021 36.945
201712 23.777 109.404 35.702
201803 25.587 109.786 38.286
201806 25.687 111.317 37.907
201809 27.441 115.142 39.150
201812 28.248 115.142 40.301
201903 27.084 118.202 37.640
201906 30.312 120.880 41.193
201909 31.100 123.175 41.477
201912 31.015 126.235 40.360
202003 28.894 124.705 38.062
202006 21.546 127.000 27.869
202009 21.353 130.118 26.958
202012 21.608 130.889 27.119
202103 23.127 131.771 28.831
202106 25.448 134.084 31.177
202109 26.041 135.847 31.490
202112 27.530 138.161 32.733
202203 21.767 138.822 25.758
202206 28.772 142.347 33.204
202209 29.921 144.661 33.977
202212 30.173 145.763 34.004
202303 30.285 146.865 33.875
202306 32.420 150.280 35.439
202309 34.524 151.492 37.437
202312 33.524 152.924 36.012
202403 33.353 153.035 35.802
202406 37.124 155.789 39.146
202409 39.067 157.882 40.648
202412 38.900 158.323 40.362
202503 41.221 157.552 42.979
202506 43.523 159.755 44.754
202509 45.715 162.289 46.274
202512 45.235 163.281 45.510
202603 44.951 164.272 44.951

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹144.84 mean?
HealthCare Global Enterprises (NSE:HCG) has a Cyclically Adjusted Revenue per Share of ₹144.84 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on HealthCare Global Enterprises and its competitors.
Is HealthCare Global Enterprises' Cyclically Adjusted Revenue per Share too high?
HealthCare Global Enterprises' current Cyclically Adjusted Revenue per Share is ₹144.84. Overall, HealthCare Global Enterprises has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' Cyclically Adjusted Revenue per Share compare to HCA and THC?
HealthCare Global Enterprises' Cyclically Adjusted Revenue per Share of ₹144.84 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on HealthCare Global Enterprises and its competitors. HealthCare Global Enterprises's current Cyclically Adjusted Revenue per Share is ₹144.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹581.71, compared to a current price of ₹670.95 — trading 15.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹144.84. HealthCare Global Enterprises' overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current Cyclically Adjusted Revenue per Share is ₹144.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹670.95 is trading 15.3% above its estimated GF Value™ of ₹581.71. GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.

Key valuation signals for NSE:HCG:

  • Cyclically Adjusted Revenue per Share: ₹144.84
  • GF Value™: ₹581.71 vs. price of ₹670.95 (15.3% above fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
82GF Score

Get the complete analysis for NSE:HCG

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹670.95
Price
₹581.71
GF Value